Geraldina Dominguez, Ph.D.

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Dr. Geraldina Dominguez received her B.S. in Applied Biology from the Georgia Institute of Technology and her Ph.D. from Georgia State University.  Dr. Dominguez received a Resident Research Associateship from the National Research Council to study the genetic and genomic structure of human herpesviruses 6,7 and 8 at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.  

After CDC, she moved to the Yerkes National Primate Center of Emory University to conduct studies on the signal transduction pathways and transcriptional regulation of the CART gene (Cocaine and Amphetamine Regulated Transcript).  

In 2004, Dr. Dominguez started working at the National Cancer Institute as an International Project Officer in the Office of International Affairs, and in 2005 she accepted a Program Director position in the Office of HIV and AIDS Malignancy (OHAM). Currently, she serves as the Director of the AIDS Malignancy Program in OHAM. Dr. Dominguez plays a major role in developing and managing HIV and AIDS malignancy initiatives, including initiatives that increase research capacity in resource constrained settings.

Dr. Dominguez has received two NIH Director’s Awards and one NCI Award of Merit for her role in supporting initiatives that build research capacity in resource constrained regions.

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source and a link to this page included, e.g., “Geraldina Dominguez, Ph.D. was originally published by the National Cancer Institute.”

Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artists, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.